Skip to product information
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors. Under active scientific investigation for metabolic pathway research. Lyophilized powder per vial. ≥99.2% HPLC purity verified.
Reta
$200.00